Evidence map›Paper›PMID 29463534›Full record

ArticleAntimicrobial agents and chemotherapy2018

Alginate Oligosaccharide-Induced Modification of the

Alison A Jack, Saira Khan, Lydia C Powell, Manon F Pritchard, Konrad Beck, Hina Sadh, Lucy Sutton, Alessandra Cavaliere, Hannah Florance, Philip D Rye and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Theophylline as a quorum sensing and biofilm inhibitor in Pseudomonas aeruginosa and Chromobacterium violaceum.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Infectious medicine · 2023
    Review
  11. Response ofMarine life science & technology · 2023
    Article
  12. Heliyon · 2023
    Article
  13. Review
  14. The Molecular Architecture ofMarine drugs · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Alison A JackAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Saira KhanAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Lydia C PowellAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Manon F PritchardAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Konrad BeckAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Hina SadhAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Lucy SuttonAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Alessandra CavaliereSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, United Kingdom.
Hannah FloranceDepartment of Biosciences, College of Life and Environmental Sciences, Exeter University, Exeter, United Kingdom.
Philip D RyeAlgiPharma AS, Sandvika, Norway.
David W ThomasAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom.
Katja E HillAdvanced Therapies Group, Cardiff University School of Dentistry, Cardiff, United Kingdom hillke1@cardiff.ac.uk.ORCID 0000-0002-8590-0117
Cardiff University · GBAlgiPharma (Norway) · NOUniversity of Exeter · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

4-ButyrolactoneAnti-Bacterial AgentsBiofilmsPseudomonas aeruginosaQuorum Sensing4-ButyrolactoneAnti-Bacterial Agentshomoserine lactonealginatebiofilmshomoserine lactonenatural antimicrobial productsOligoG CF-5/20Pseudomonas aeruginosaquorum-sensing inhibitor

Identifiers

PMID29463534
PMCPMC5923140
OpenAlexW2793928847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.